Neuropace Correlations

NPCE Stock  USD 6.68  0.04  0.60%   
The current 90-days correlation between Neuropace and Electromed is 0.09 (i.e., Significant diversification). The correlation of Neuropace is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Neuropace Correlation With Market

Weak diversification

The correlation between Neuropace and DJI is 0.37 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neuropace. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For information on how to trade Neuropace Stock refer to our How to Trade Neuropace Stock guide.

Moving together with Neuropace Stock

  0.67ESTA Establishment LabsPairCorr
  0.62EBS Emergent Biosolutions Upward RallyPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
NVROSRDX
CNMDITGR
CNMDELMD
GKOSITGR
ITGRELMD
FNAKIDS
  
High negative correlations   
SRDXELMD
GKOSSRDX
ITGRSRDX
CNMDSRDX
GKOSNVRO
NUVAFNA

Risk-Adjusted Indicators

There is a big difference between Neuropace Stock performing well and Neuropace Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Neuropace's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ELMD  2.51  0.41  0.14  0.57  2.59 
 6.65 
 13.47 
KIDS  2.55 (0.22) 0.00 (0.03) 0.00 
 7.54 
 15.43 
SRDX  0.42 (0.15) 0.00 (1.18) 0.00 
 0.86 
 3.10 
FNA  3.51 (0.08) 0.01  0.07  5.79 
 7.56 
 31.88 
NVRO  4.69 (0.77) 0.00 (0.07) 0.00 
 10.07 
 54.41 
NUVA  1.23 (0.04) 0.00 (0.31) 0.00 
 3.31 
 7.19 
ITGR  1.36  0.06  0.03  0.17  1.91 
 2.54 
 11.18 
GKOS  1.45  0.09  0.05  0.19  1.56 
 3.69 
 8.11 
CNMD  1.77  0.05  0.03  0.15  2.06 
 4.92 
 12.82 
OSA  104.70  59.71  1.97 (0.79) 13.81 
 51.22 
 168.97 

Neuropace Corporate Management